BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 6, 2004
View Archived Issues
Tarceva accepted onto FDA Pilot 1 Program
Read More
Xenon Genetics changes name to Xenon Pharmaceuticals
Read More
Large Scale Biology and the U. of Louisville collaborate on HPV-associated cancers
Read More
Phase Ic results of PYY3-36 nasal spray for obesity
Read More
Alcon files second portion of Retaane rolling NDA
Read More
Enrollment under way in two phase III Leukine studies for Crohn's disease
Read More
New phase II study of Telcyta combination front-line treatment of NSCLC
Read More
Merck & Co. and Alnylam collaborate on RNAi therapeutics for ocular diseases
Read More
BioXell acquires from Roche rights to new indications for BXL-628
Read More
Eisai launches Apnission in Japan
Read More
Acetylcholinesterase inhibitor ITH-4012 shows calcium promoting and neuroprotective activity
Read More
Centocor and Fujisawa discontinue codevelopment of abciximab in Japan
Read More
CoTherix submits NDA for Ventavis
Read More
OPi and Vaccinex establish antibody collaboration
Read More
European orphan drug designation recommended for Surfaxin
Read More
Striant SR submitted for mutual recognition procedure in Europe
Read More
Mitsubishi Pharma describes series of cyclic amide derivatives
Read More
COX-2 inhibitors presented by CJ Corporation
Read More
Achillion Pharmaceuticals claims inhibitors of hepatitis C virus replication
Read More
Ubiquitination inhibitors in early development at Rigel
Read More
BMS scientists prepare and test novel selective androgen receptor modulators
Read More
Sumitomo discloses agents for fibrosis in patent literature
Read More
Modafinil beneficial in patients with schizophrenia
Read More
Development of LJP-1082 and LJP-394 reviewed
Read More
Novel potent and selective T-type calcium channel blockers
Read More
